Skip to main content

Month: March 2023

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive HCM, Supporting Advancement to Phase 3 Additional Results from FOREST-HCM Demonstrate Long-Term Treatment with Aficamten for 48 Weeks is Well-Tolerated and Associated with Sustained Treatment Effect Company to Host Investor Event and Conference Call on March 6, 2023 at 8:30 AM Eastern Time SOUTH SAN FRANCISCO, Calif., March 04, 2023 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that positive results from Cohort 4 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), a Phase 2 clinical trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM), were presented at the American College of...

Continue reading

Lexicon Reveals “INTO THE DARK” Awareness Campaign About Vulnerable and Dangerous Period of Time Faced by Heart Failure Patients Following Hospitalization

Into the Dark Into the Dark Campaign ImageEmphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization Reinforces impact of rehospitalizations for heart failure patients and healthcare system Campaign launches at American College of Cardiology’s 72nd Annual Scientific Session Together with World Congress of Cardiology THE WOODLANDS, Texas, March 04, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the launch of a new disease awareness campaign focused on the cyclical nature of rehospitalizations for heart failure (HF) patients. The “INTO THE DARK” campaign focuses on the first 30 days following a heart failure patient’s hospitalization, which is the “danger zone” where the likelihood of poor outcomes, including rehospitalization,...

Continue reading

CORRECTION TO SUMMONS TO ROBIT PLC’S ANNUAL GENERAL MEETING 2023

ROBIT PLC          STOCK EXCHANGE RELEASE          4 MARCH 2023 AT 12.00 P.M. CORRECTION TO SUMMONS TO ROBIT PLC’S ANNUAL GENERAL MEETING 2023 In summons to Robit Plc’s AGM 2023 published on 20 February 2023 at 12.00 pm, the Board of Directors proposed that a dividend of EUR 0.02 per share would be distributed for the 2022 financial period. The Board of Directors withdraws the proposal of payment of dividends and proposes to the AGM that EUR 0.02 per outstanding share be paid from the company’s distributable funds to the shareholders. The corrected summons to the AGM 2023 is as follows: The shareholders of Robit Plc are hereby invited to the Annual General Meeting to be held on Wednesday, 15 March 2023 from 2.00 pm onwards at Tampere Hall, address Yliopistonkatu 55, 33100, Tampere, Finland. The reception of registered participants and...

Continue reading

Blender Bites Receives Several US Purchase Orders and is Set to Unveil its Latest Functional Food Innovation at the Largest Natural Food Expo in the World¹

VANCOUVER, British Columbia, March 03, 2023 (GLOBE NEWSWIRE) — Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), an award-winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to announce that it has received multiple purchase orders following its US tradeshow debut at the KeHE Summer show (the “Summer Show” or the “Tradeshow”), held Feb 7th and February 8th in Nashville, Tennessee, and also announces that it will unveil its latest functional food innovation – the 1-Step Frappé – at the upcoming Natural Products Expo West (“Expo West” or the “Expo”), next week. The Summer Show marked the kick off Blender Bites’ US launch with KeHE Distributors, LLC (“KeHE” the “Distributor”),...

Continue reading

Central 1 Reports 2022 Financial Results

VANCOUVER, British Columbia, March 03, 2023 (GLOBE NEWSWIRE) — Central 1 Credit Union (‘Central 1’ or ‘the organization’) reported a loss of $69.6 million for the year ended December 31, 2022, compared to a profit of $45.4 million in 2021. “Our 2022 financial story is reflective of the challenging market conditions during the year which has resulted in unrealized losses on our fixed income investments, but also stable performance in our core operations and revenue sources like interest margin, which remained strong,” said Sheila Vokey, Central 1 President & CEO. “Our Treasury team effectively managed Central 1’s portfolio which is predominately fixed income investments, supporting our Credit Union members with the provision of solid liquidity services. Our continued focus on enabling and supporting our members and clients...

Continue reading

Century Aluminum CEO Jesse Gary Thanks the Biden Administration for Invitation to Participate in Roundtable Discussion on Industrial Innovation and Decarbonization

CHICAGO, March 03, 2023 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today released the following statement from President and Chief Executive Officer Jesse Gary after his visit to the White House for a roundtable discussion with other industry leaders and labor leaders to discuss industrial innovation and decarbonization efforts: “Thank you to the Biden Administration for inviting Century to the White House on this important occasion. As we have stated before, Century Aluminum fully supports the Biden administration’s efforts to decarbonize industrial production through innovation. “To move forward in continuing to support a viable domestic aluminum industry, Century is committed to maintaining critical manufacturing capabilities in the U.S. and to protecting American jobs, and doing so sustainably while also greening...

Continue reading

Kane Biotech Clarifies Terms of Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, March 03, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that, as previously announced by the Company in its March 1, 2023 press release, pursuant to the formal amending agreement (the “Amending Agreement”) with Pivot Financial I Limited Partnership (“Pivot”) dated March 2, 2023 amending the terms of the Company’s amended and restated credit agreement between Pivot and the Company dated August 31, 2021, as amended (the “Credit Facility”), the interest rate of the Credit Facility increased from 14% to 15% per annum. The Company previously announced the Amending Agreement on March 2, 2023 and March 1, 2023. About Kane Biotech Kane Biotech is a biotechnology company...

Continue reading

Gatos Silver Provides Bi-Weekly Status Report

VANCOUVER, British Columbia, March 03, 2023 (GLOBE NEWSWIRE) — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). In its March 18, 2022 news release (the “Notice”), the Company announced the delay in the filing of its annual report on Form 10-K for the year ended December 31, 2021, which includes its audited consolidated financial statements as at and for the year ended December 31, 2021, together with the auditor’s report thereon and the notes thereto, its management’s discussion and analysis for the year ended December 31, 2021 relating to the audited annual financial statements, and the Chief Executive Officer and Chief Financial Officer certificates relating to its...

Continue reading

Grupo Aeroportuario del Pacifico Reports in February 2023 a Passenger Traffic Increase of 24.3% Compared to 2022

GUADALAJARA, Mexico, March 03, 2023 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for the month of February 2023, compared with the same period of 2022. For February 2023, the total number of terminal passengers at GAP’s 12 Mexican airports increased by 21.8%, compared to the same period of 2022. Puerto Vallarta, Guadalajara, Los Cabos, and Tijuana presented an increase in passenger traffic of 31.9%, 26.0%, 24.5%, and 12.5% respectively, compared to February 2022. On the other hand, Montego Bay increase by 49.5% and Kingston 43.0%, compared to 2022.Domestic Terminal Passengers (in thousands):Airport Feb-22 Feb-23 % Change Jan – Feb 22 Jan – Feb 23 % ChangeGuadalajara 735.3 913.7 24.3% 1,472.8 1,904.8 29.3%Tijuana* 562.5 636.1 13.1% 1,155.3 1,349.7 16.8%Los...

Continue reading

NuLegacy Gold Engages the 121 Group for Investor Relations Services

RENO, Nev., March 03, 2023 (GLOBE NEWSWIRE) — NuLegacy Gold Corporation announces that it has engaged the 121 Group (HK) Limited under its Assay Investor Engagement Program (the “121 Group”) to provide investor relations services including dissemination of Company news releases and the creation and maintenance of marketing content in both digital and print form. All content and news coverage will be shared with 121 Group’s network of institutional investors and other subscribers through The Assay website (www.theassay.com), 121 Group’s social media platforms (Twitter, LinkedIn and YouTube), through The Assay Weekly Newsletter and The Assay Magazine digital and print editions where applicable. Under the agreement, the 121 Group will provide services for a twelve-month term at a total upfront cost of USD$15,000. No stock options...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.